HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Current Clinical Trial for Mesothelioma Patients: Bortezomib

Read about a current clinical trial being conducted to study the effects of Bortezomib for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the clinical trials are not being conducted in the United States.

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Rational and Purpose

Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying the side effects of Bortezomib and how well it works in treating patients with malignant pleural mesothelioma.

Study Description
Phase, Type and Design: Phase II Interventional study; Treatment, Non-Randomized, Open Label; An Open Label Phase II Multicentre Clinical Trial of Single Agent Bortezomib in Patients With Malignant Pleural Mesothelioma

Intervention:
Drug: Bortezomib; Procedure: enzyme inhibitor therapy; quality-of-life assessment

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Bortezomib trial description for mesothelioma
Bortezomib and Cisplatin in mesothelioma trial
Outcomes of Bortezomib against mesothelioma cancer
Mesothelioma: Bortezomib Criteria
Effects of Bortezomib trial on mesothelioma cancer
Bortezomib therapy for mesothelioma patients
Bortezomib therapy for mesothelioma patients
Bortezomib and Cisplatin in mesothelioma trial


RETURN BACK TO
Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Mesothelioma: Bortezomib Criteria NY asbestos lawyers: Criteria to treat mesothelioma with Bortezomib
Free case review; Bortezomib mesothelioma therapy criteria over here

Effects of Bortezomib trial on mesothelioma cancer Clinical trial to study effects of Bortezomib on mesothelioma patients
The effects of Bortezomib clinical trial on mesothelioma patients

Pazopanib inclusion criteria at mesothelioma trial Inclusion criteria for Pazopanib trial on mesothelioma patients
Patient inclusion criteria for Pazopanib trial against mesothelioma